Protalix BioTherapeutics Statistics
Total Valuation
PLX has a market cap or net worth of $263.92 million. The enterprise value is $224.53 million.
| Market Cap | 263.92M |
| Enterprise Value | 224.53M |
Important Dates
The last earnings date was Tuesday, November 10, 2026, before market open.
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PLX has 84.32 million shares outstanding. The number of shares has decreased by -3.09% in one year.
| Current Share Class | 84.32M |
| Shares Outstanding | 84.32M |
| Shares Change (YoY) | -3.09% |
| Shares Change (QoQ) | +1.24% |
| Owned by Insiders (%) | 3.71% |
| Owned by Institutions (%) | 24.72% |
| Float | 81.19M |
Valuation Ratios
The trailing PE ratio is 12.71 and the forward PE ratio is 52.17.
| PE Ratio | 12.71 |
| Forward PE | 52.17 |
| PS Ratio | 3.12 |
| Forward PS | 3.89 |
| PB Ratio | 3.21 |
| P/TBV Ratio | 3.28 |
| P/FCF Ratio | 17.52 |
| P/OCF Ratio | 15.03 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.37, with an EV/FCF ratio of 14.90.
| EV / Earnings | 10.93 |
| EV / Sales | 2.65 |
| EV / EBITDA | 8.37 |
| EV / EBIT | 8.91 |
| EV / FCF | 14.90 |
Financial Position
The company has a current ratio of 3.27, with a Debt / Equity ratio of 0.11.
| Current Ratio | 3.27 |
| Quick Ratio | 2.07 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.32 |
| Debt / FCF | 0.61 |
| Interest Coverage | 30.59 |
Financial Efficiency
Return on equity (ROE) is 30.80% and return on invested capital (ROIC) is 49.42%.
| Return on Equity (ROE) | 30.80% |
| Return on Assets (ROA) | 15.71% |
| Return on Invested Capital (ROIC) | 49.42% |
| Return on Capital Employed (ROCE) | 28.64% |
| Weighted Average Cost of Capital (WACC) | 4.25% |
| Revenue Per Employee | $374,748 |
| Profits Per Employee | $90,934 |
| Employee Count | 226 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 1.56 |
Taxes
In the past 12 months, PLX has paid $5.30 million in taxes.
| Income Tax | 5.30M |
| Effective Tax Rate | 20.49% |
Stock Price Statistics
The stock price has increased by +46.95% in the last 52 weeks. The beta is -0.02, so PLX's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | +46.95% |
| 50-Day Moving Average | 2.67 |
| 200-Day Moving Average | 2.44 |
| Relative Strength Index (RSI) | 71.22 |
| Average Volume (20 Days) | 871,005 |
Short Selling Information
The latest short interest is 3.51 million, so 4.16% of the outstanding shares have been sold short.
| Short Interest | 3.51M |
| Short Previous Month | 2.88M |
| Short % of Shares Out | 4.16% |
| Short % of Float | 4.32% |
| Short Ratio (days to cover) | 3.96 |
Income Statement
In the last 12 months, PLX had revenue of $84.69 million and earned $20.55 million in profits. Earnings per share was $0.25.
| Revenue | 84.69M |
| Gross Profit | 41.42M |
| Operating Income | 25.21M |
| Pretax Income | 25.85M |
| Net Income | 20.55M |
| EBITDA | 26.83M |
| EBIT | 25.21M |
| Earnings Per Share (EPS) | $0.25 |
Balance Sheet
The company has $48.54 million in cash and $9.15 million in debt, with a net cash position of $39.39 million or $0.47 per share.
| Cash & Cash Equivalents | 48.54M |
| Total Debt | 9.15M |
| Net Cash | 39.39M |
| Net Cash Per Share | $0.47 |
| Equity (Book Value) | 80.55M |
| Book Value Per Share | 0.98 |
| Working Capital | 68.64M |
Cash Flow
In the last 12 months, operating cash flow was $17.56 million and capital expenditures -$2.49 million, giving a free cash flow of $15.07 million.
| Operating Cash Flow | 17.56M |
| Capital Expenditures | -2.49M |
| Depreciation & Amortization | 1.62M |
| Net Borrowing | n/a |
| Free Cash Flow | 15.07M |
| FCF Per Share | $0.18 |
Margins
Gross margin is 48.91%, with operating and profit margins of 29.76% and 24.27%.
| Gross Margin | 48.91% |
| Operating Margin | 29.76% |
| Pretax Margin | 30.52% |
| Profit Margin | 24.27% |
| EBITDA Margin | 31.67% |
| EBIT Margin | 29.76% |
| FCF Margin | 17.79% |
Dividends & Yields
PLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.09% |
| Shareholder Yield | 3.09% |
| Earnings Yield | 7.87% |
| FCF Yield | 5.71% |
Analyst Forecast
| Price Target | $11.00 |
| Price Target Difference | 251.44% |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 13.43% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on December 20, 2019. It was a reverse split with a ratio of 1:10.
| Last Split Date | Dec 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
PLX has an Altman Z-Score of 0.79 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.79 |
| Piotroski F-Score | 5 |